# Caffeine and Cerebrovascular Reactivity

> **NCT04730193** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Oklahoma** · enrollment: 10 (actual)

## Conditions studied

- Caffeine

## Interventions

- **DRUG:** Caffeine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04730193
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-01
- **Primary completion:** 2022-08-01
- **Final completion:** 2022-08-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04730193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04730193, "Caffeine and Cerebrovascular Reactivity". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04730193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*